Advertisement
News
Subscribe to MDT Magazine News

Improvements in Recurrence-Free Survival in Early Stages of Colorectal Cancer Will Limit Growth of Drug Treatment Opportunities for Advanced Disease

December 16, 2010 9:35 am | by Bio-Medicine.Org | Comments

BURLINGTON, Mass., Dec. 16, 2010 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that projected improvements in recurrence-free survival in early stages of colorectal cancer is the most important factor limiting...

TOPICS:

FDA Begins Process To Remove Breast Cancer Indication From Avastin Label

December 16, 2010 9:35 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Dec. 16, 2010 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective...

TOPICS:

Fenwal Receives FDA Clearance for Wireless Data Export on ALYX Blood-Collection System

December 16, 2010 9:35 am | by Bio-Medicine.Org | Comments

LAKE ZURICH, Ill., Dec. 16, 2010 /- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its ALYX™ component...

TOPICS:
Advertisement

Beaumont Hospital Launches Study of Single-Dose Radiation Treatment for Prostate Cancer

December 16, 2010 9:34 am | by Bio-Medicine.Org | Comments

ROYAL OAK, Mich., Dec. 16, 2010 /- Beaumont Hospital radiation oncologists have launched a research study to treat men with low to intermediate risk prostate cancer with a single dose of radiation. Alvaro Martinez, M.D., FACR, professor and chair, Oakland University William Beaumont...

TOPICS:

Cardica makes deal to sell $10 million in shares

December 16, 2010 6:45 am | by The Associated Press | Comments

Surgical systems maker Cardica Inc. said Thursday that it has made a deal to sell Chicago-based institutional investor Aspire Capital Fund LLC up to $10 million of its shares over the next two years.Cardica President and CEO Dr. Bernard A. Hausen said the access to money from Aspire will give...

Gentiva reaffirms 2010 outlook, sets 2011 guidance

December 16, 2010 6:45 am | by The Associated Press | Comments

Home health services company Gentiva Health Services Inc. on Thursday reaffirmed its 2010 financial outlook and set guidance for 2011.The company expects adjusted profit from continuing operations between $2.75 and $2.80 on revenue between $1.42 billion and $1.45 billion in 2010. Analysts...

AmerisourceBergen reaffirms fiscal 2011 guidance

December 16, 2010 6:45 am | by The Associated Press | Comments

Drug distributor AmerisourceBergen Corp. said it will reaffirm its previous guidance for fiscal 2011 at its investor day meeting in New York on Thursday.The company expects earnings per share for the 2011 fiscal year to be from $2.31 to $2.41, up 7 percent to 12 percent from the $2.16 per share...

Novavax moving forward with vaccine study

December 16, 2010 6:45 am | by The Associated Press | Comments

Novavax Inc. said Thursday it will conduct an early-stage study on its potential vaccine for respiratory syncytial virus, following the resolution of a Food and Drug Administration request.Respiratory syncytial virus, or RSV, infects about 8.5 million adults every year and can cause severe...

Advertisement

IMEC details 3D Cost Modeling at Munich IEEE 3DIC Conference

December 16, 2010 6:33 am | by I-Micronews | Comments

At the recent IEEE 3DIC Conference held in Munich, IMEC detailed their cost model developed to analyze and compare the cost effectiveness of different 3D technology solutions. Based on IMEC?s 3D integration process flows, the model includes the cost of manufacturing equipment, fabrication...

Solta Medical Ships One Millionth Tip for Thermage and Fraxel Devices

December 16, 2010 6:32 am | by Bio-Medicine.Org | Comments

HAYWARD, Calif., Dec. 16, 2010 /- Solta Medical, Inc. (Nasdaq: SLTM ), the pioneer in fractional resurfacing and non-invasive skin tightening and a market leader in aesthetic skin treatments, today announced it has shipped its one millionth tip for the revolutionary Thermage and Fraxel...

TOPICS:

ERT Unveils Full Range of ePRO Solutions Providing the Power of Choice for Clinical Trial Sponsors

December 16, 2010 6:31 am | by RealWire | Comments

PHILADELPHIA, PA, 16 December 2010 ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of its comprehensive suite of electronic patient-reported outcome (ePRO) solutions. As the ePRO market...

TOPICS:

NOVAVAX Receives FDA Clearance to Launch Phase I RSV Vaccine Clinical Trial

December 16, 2010 5:31 am | by Bio-Medicine.Org | Comments

ROCKVILLE, Md., Dec. 16, 2010 /- Novavax, Inc. (Nasdaq: NVAX ) announced today that the company's Phase I clinical trial to evaluate a new vaccine candidate to prevent respiratory syncytial virus (RSV) infection has been cleared by the U.S. Food and Drug Administration (FDA) and is no...

TOPICS:

FDA Safety Notification: Risk of Eye and Skin Injuries from High-powered, Hand-held Lasers Used for Pointing or Entertainment

December 16, 2010 5:30 am | by U.S. Food & Drug Administration | Comments

The FDA is alerting consumers about the risk of eye and skin injuries from exposure to high-powered laser pointers. FDA regulations limit the energy output of hand-held laser pointers to 5 milliwatts (mW).

TOPICS:

Judge invalidates state contract to Blue Cross

December 16, 2010 4:45 am | by The Associated Press | Comments

A judge Wednesday invalidated a contract the state awarded to Blue Cross and Blue Shield of Louisiana to administer the HMO plan for state workers, retirees and their dependents.State District Judge Mike Caldwell agreed with attorneys for Humana and UnitedHealthcare that the contract awarded...

Is OSRAM for sale?

December 16, 2010 4:34 am | by I-Micronews | Comments

Siemens AG, Europe’s largest engineering company, is exploring options for its Osram lighting business, including a possible initial public offering or sale, according to three people with knowledge of the discussions. Siemens, ...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading